Rydapt®▼ (midostaurin) [1]
More information
For more information about Rydapt please consult:
Summary of product characteristics (SmPC) GB [2] for Rydapt
This link will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.
Patient information leaflet (PIL) GB [3] for Rydapt
This link will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.
Summary of product characteristics (SmPC) NI [4] for Rydapt
This link will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.
Patient information leaflet (PIL) NI [5] for Rydapt
This link will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.
Rydapt is not subject to additional monitoring in Northern Ireland.
This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.mhra.gov.uk/yellowcard [6] for how to report side effects.
Reference
- Rydapt Summary of Product Characteristics.